The Top Workplace USA Awards are designed to recognize organizations around the country that have cultivated exceptional workplace cultures…

CarepathRx will assist Knox Community Hospital in building a comprehensive specialty pharmacy program…

MERCER ISLAND, Wash., Nov. 9, 2022 – CarepathRx, a portfolio company of Nautic Partners, LLC (“Nautic”) and leader in pharmacy and medication management solutions, today announced the sale of BioPlus Specialty Pharmacy, the nation’s largest independent specialty pharmacy, to Elevance Health.

BioPlus is a leading specialty pharmacy serving patients in all 50 states and across various therapeutic categories. As one of the most innovative specialty pharmacies, BioPlus has demonstrated the highest level of commitment to patient care, delivering solutions that seek to improve the care journey for those suffering from chronic and life-changing diseases. The success at BioPlus has led to numerous awards and industry achievements.

“Since partnering with CarepathRx and Nautic, we believe BioPlus has had a far reaching impact on our patients, prescribing partners, and payers and has achieved best-in-class patient satisfaction over the last three years. We thank the CarepathRx leadership and Nautic team for their support and partnership and look forward to continued growth,” said Mark Montgomery, CEO of BioPlus.

“We are excited for the BioPlus team and are confident that the business will continue to provide a tremendous positive impact going forward. The entire CarepathRx team thanks Mark Montgomery and the rest of the BioPlus staff for their incredible efforts, including the leadership and vision of the late Dr. Steven Vogt, without whom none of this would have been possible,” said John Figueroa, Chairman & CEO of CarepathRx.

Post-closing of the BioPlus transaction, CarepathRx will seek to continue its mission of revolutionizing pharmacy services for patients undergoing complicated medications therapies. Through its CarepathRx Health Systems Solutions (“CHSS”) and ExactCare Pharmacy (“ExactCare”) businesses, CarepathRx will look to accelerate its comprehensive pharmacy services to the hospital market, other risk-bearing providers, and payer partners.

“Since its founding in 2019, CarepathRx has experienced strong growth and has built a comprehensive portfolio of pharmacy service solutions, partnering with over 600 hospital systems, 450 payers, and other risk-bearing provider partners to dispense over 8 million prescriptions annually. We believe we remain the only independent company partnering with health systems delivering specialty pharmacy and infusion pharmacy management services, as well as polypharmacy discharge and transitions of care services for the chronically ill. We also believe that the sale of BioPlus will allow CarepathRx to materially accelerate our investment in CHSS and ExactCare, dramatically broadening our impact on the healthcare market,” said Mr. Figueroa.

The transaction is subject to the expiration or termination of applicable waiting periods under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and other customary closing conditions and is expected to close by the end of the first quarter of 2023.

Centerview Partners acted as lead financial advisor and Cantor Fitzgerald is also acting as financial advisor to CarepathRx and Nautic. Kirkland & Ellis, LLP acted as legal advisor to CarepathRx and Nautic.

About CarepathRx
CarepathRx seeks to transform pharmacy care delivery for health systems and hospitals by delivering improved patient outcomes that drive clinical, quality, and financial results. Through industry leading, comprehensive, end-to-end hospital pharmacy care delivery model, CarepathRx works to turn hospital pharmacy into an active care management strategy and revenue generator while providing support across the patient’s complete healthcare journey. The company takes an enterprise approach, providing a powerful combination of technology, market-leading clinical pharmacy services, and wrap-around services that aim to optimize pharmacy performance for fully integrated pharmacy operations, expanded healthcare services, improved ambulatory access, minimized clinical variation and new health system revenue streams. Today, CarepathRx serves more than 20 health systems and 600 hospitals, with more than 2,000 employees nationwide. For more information about CarepathRx, visit www.carepathrxllc.com.

About Nautic
Nautic Partners, LLC (“Nautic”) is a middle-market private equity firm that focuses on three industries: healthcare, industrials, and services. Nautic has completed over 150 platform transactions throughout its 35-plus year history. Nautic’s strategy is to partner with management teams to accelerate the growth trajectory of its portfolio companies via add-on acquisitions, targeted operating initiatives, and increased management team depth. For more information, please visit www.nautic.com.

MERCER ISLAND, Wash., Oct. 12, 2022 – CarepathRx, a leader in pharmacy and medication management solutions, today announced a new partnership with Yale New Haven Health System (YNHHS) to provide comprehensive home infusion services to the health system’s patient population. This partnership will allow YNHHS to extend its reach into the home setting with services including intake, nursing, billing, reporting, and analytics.

“CarepathRx is excited to partner with Yale New Haven Health to facilitate the expansion of patient access to home infusion therapies,” said Keith Crawford, Chief Strategy Officer, CarepathRx. “An enticing option for patients and providers, alike, home infusion is safe, effective, and can increase the quality of life for patients, while minimizing health care costs.”

Yale New Haven Health, headquartered in New Haven, Conn., serves as the state’s largest healthcare provider. The network is made up of five hospitals dedicated to various services that include cancer centers, a psychiatric hospital, an ambulatory services division, and more. 

“The opportunity to collaborate with CarepathRx will enhance patient care through access to home infusion solutions not previously available,” said LeeAnn Miller, VP, Chief Pharmacy Officer, YNHHS.

About CarepathRx

CarepathRx is transforming pharmacy care delivery for health systems and hospitals, delivering improved patient outcomes that drive clinical, quality, and financial results. Through the industry’s most comprehensive, end-to-end hospital pharmacy care delivery model, CarepathRx is turning hospital pharmacy into an active care management strategy and revenue generator while providing support across the patient’s complete healthcare journey. The company takes an enterprise approach, providing a powerful combination of technology, market-leading clinical pharmacy services, and wrap-around services that optimize pharmacy performance across the enterprise for fully integrated pharmacy operations, expanded healthcare services, improved ambulatory access, minimized clinical variation and new health system revenue streams. Today, CarepathRx serves more than 20 health systems and 600 hospitals, with more than 1,500 employees nationwide. For more information about CarepathRx, visit www.carepathrxllc.com.

MERCER ISLAND, Wash., Sept. 12, 2022 – CarepathRx, a leader in pharmacy and medication management solutions, announced today a multi-year infusion management service agreement with Orlando Health. 

Orlando Health is a 3,200-bed system that includes ten award-winning hospitals, nine hospital-based ERs, seven free-standing emergency rooms, and more than 4,200 physicians – representing over 100 medical specialties and subspecialties across the health system. Orlando Health employs more than 23,000 team members. Orlando Health’s first home infusion is scheduled for mid-September.

“We’re excited to partner with CarepathRx to provide this high-quality care at home,” said George Ralls, MD, Orlando Health Chief Medical Officer. “The new service is cost-effective and more convenient for our patients.”

“I’m very pleased about our new partnership with Orlando Health,” said John Figueroa, CEO of CarepathRx. “We are honored to be working with Orlando Health to expand their service capabilities to provide infusion therapies in the home.”

“CarepathRx is excited about our new relationship with Orlando Health,” said Keith Crawford, Chief Strategy Officer at CarepathRx. “Expanding their pharmacy services to include home infusion will allow Orlando Health the ability to broaden the care they provide to the community. CarepathRx is thrilled to work with Orlando Health to transform patient care and improve clinical outcomes, all through enhanced pharmacy operations and capabilities.”

About CarepathRx
CarepathRx is transforming pharmacy care delivery for health systems and hospitals, delivering improved patient outcomes that drive clinical, quality, and financial results. Through the industry’s most comprehensive, end-to-end hospital pharmacy care delivery model, CarepathRx is turning hospital pharmacy into an active care management strategy and revenue generator while providing support across the patient’s complete healthcare journey. The company takes an enterprise approach, providing a powerful combination of technology, market-leading clinical pharmacy services, and wrap-around services that optimize pharmacy performance across the enterprise for fully integrated pharmacy operations, expanded healthcare services, improved ambulatory access, minimized clinical variation and new health system revenue streams. Today, CarepathRx serves more than 15 health systems and 600 hospitals, with more than 1,500 employees nationwide. For more information about CarepathRx, visit www.carepathrxllc.com.